IL6 and atherosclerosis: The innate immune response is activated through Toll-like receptor 4 (TLR4) when LPS levels increase, thus promoting vascular inflammation and atherosclerosis by elevating inflammatory cytokines interleukin-6 (IL-6) and IL-8.